HAS2 dysregulation in IPF (Li et al., 2016) and the effects of RHAMM antibodies and peptide mimetics in reducing macrophage recruitment and early fibrosis (Zaman et al., 2005) highlight the connection between RHAMM, hyaluronan, and IPF. The gene discussed is HAS2; the disease is idiopathic pulmonary fibrosis.